Non-Small Cell Lung Cancer Harboring Concurrent <i>EGFR</i> Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma

Slični predmeti

• Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
  od: Valerio Gristina, i dr.
  Izdano: (2021-07-01)
• The diagnostic accuracy of mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis
  od: Antonio Galvano, i dr.
  Izdano: (2022-09-01)
• The Emerging Therapeutic Landscape of ALK Inhibitors in Non-Small Cell Lung Cancer
  od: Valerio Gristina, i dr.
  Izdano: (2020-12-01)
• pathogenic variants in triple-negative luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
  od: Lorena Incorvaia, i dr.
  Izdano: (2020-12-01)
• Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”
  od: Andrea Gottardo, i dr.
  Izdano: (2024-03-01)